LENSAR, Inc. LNSR · Stock Open LENSAR, Inc. in new tab
LENSAR, Inc. Analysis (LNSR)
Is LENSAR, Inc. a good investment? LENSAR, Inc. (LNSR) is currently trading at 5.38 USD. Market analysts have a consensus price target of 8.50 USD. This suggests a potential upside from current levels.
Earnings Schedule: LENSAR, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -0.71.
Investor FAQ
Does LENSAR, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is LENSAR, Inc.?
LENSAR, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -0.55.
Company Profile
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Community Discussion